You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 23, 2025

Details for Patent: 10,792,278


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,792,278
Title:Methods of treating Fabry patients having renal impairment
Abstract: Provided are methods for treatment of Fabry disease in patients having HEK assay amenable mutations in .alpha.-galactosidase A. Certain methods comprise administering migalastat or a salt thereof every other day, such as administering about 150 mg of migalastat hydrochloride every other day.
Inventor(s): Castelli; Jeff (New Hope, PA), Benjamin; Elfrida (Millstone Township, NJ)
Assignee: Amicus Therapeutics, Inc. (Cranbury, NJ)
Application Number:16/817,911
Patent Claim Types:
see list of patent claims
Use; Delivery; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using United States Patent 10,792,278 as an Example

Introduction

When analyzing a U.S. patent, understanding the scope and claims is crucial for determining the patent's protection and its place within the broader patent landscape. This article will use United States Patent 10,792,278 as an example to illustrate the key components and processes involved in this analysis.

Understanding Patent Claims

Definition and Importance

Patent claims are the heart of a patent application, defining the scope of the patent's protection. They specify what the inventor considers to be the novel and non-obvious aspects of the invention[5].

Types of Claims

There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention without reference to other claims. Dependent claims, on the other hand, refer back to and further limit an independent claim[5].

Analyzing the Scope of Patent 10,792,278

Identifying the Invention

To analyze the scope of Patent 10,792,278, one must first identify the invention itself. This involves reading the specification, drawings, and claims to understand what the patent covers.

Reading the Claims

The claims section of the patent is where the legal boundaries of the invention are defined. For example, in Patent 10,792,278, the independent claims will outline the broadest definition of the invention, while the dependent claims will provide more specific limitations.

Determining Inventorship

Who Are the True and Only Inventors?

Inventorship is a critical aspect of patent law. The true and only inventors must be listed on the patent application. This involves identifying who conceived the idea and reduced it to practice[2].

Conducting a Prior Art Search

Importance of Prior Art

Before filing a patent application, it is essential to conduct a prior art search to ensure the invention is novel and non-obvious. Resources such as the USPTO's Patent Public Search tool, Global Dossier, and international patent databases like Espacenet and PATENTSCOPE can be used for this purpose[1][4].

Using USPTO Resources

The USPTO provides several tools for conducting prior art searches:

  • Patent Public Search: A modern interface for searching prior art.
  • Global Dossier: Access to file histories of related applications from participating IP Offices.
  • Public Search Facility: Physical access to patent and trademark information in Alexandria, VA.
  • Patent and Trademark Resource Centers (PTRCs): Local resources and training in patent search techniques[1].

Patent Landscape Analysis

Identifying Related Patents

To understand the patent landscape, one must identify related patents and applications. This can be done using tools like the Common Citation Document (CCD) which consolidates prior art cited by multiple offices for the same invention[1].

International Considerations

Patent protection is not limited to the U.S.; it is crucial to search international patent databases to see if the idea has been patented abroad. Resources include the European Patent Office's Espacenet, the Japan Patent Office, and the World Intellectual Property Organization's PATENTSCOPE[1][4].

Patent Prosecution Process

Filing the Application

The patent application process involves filing several documents, including the specification, drawings, oath or declaration, application data sheet, and fees. The application can be filed electronically through the USPTO's EFS-Web system or by mail/hand delivery[5].

Examination by the USPTO

After filing, a patent examiner reviews the application to ensure compliance with legal requirements and conducts a prior art search. If the examiner finds issues, an Office Action is issued, and the applicant must respond. If the claims are deemed allowable, a Notice of Allowance is sent, and the patent is issued upon payment of the issue fees[5].

Key Takeaways

  • Patent Claims: Define the scope of the patent's protection and are essential for the patent application.
  • Prior Art Search: Crucial for ensuring the invention is novel and non-obvious.
  • Inventorship: Identifying the true and only inventors is vital.
  • Patent Landscape: Understanding related patents and international considerations is key.
  • Patent Prosecution: Involves filing the application, examination by the USPTO, and potential appeals.

FAQs

What is the purpose of patent claims in a U.S. patent application?

Patent claims define the scope of the patent's protection, specifying what the inventor considers to be the novel and non-obvious aspects of the invention[5].

How do I conduct a prior art search for a U.S. patent?

You can use resources such as the USPTO's Patent Public Search tool, Global Dossier, and international patent databases like Espacenet and PATENTSCOPE to conduct a prior art search[1][4].

What is the difference between a provisional and non-provisional patent application?

A provisional application allows for an early filing date with fewer formal requirements, while a non-provisional application must be filed within 12 months and complies with all statutory requirements[5].

Who can file a patent application with the USPTO?

An inventor can file a patent application pro se or hire a registered patent attorney or patent agent to act on their behalf[5].

How long does a U.S. patent typically last?

A U.S. patent typically lasts for 20 years from the filing date of the patent application[5].

Sources

  1. USPTO: Search for patents - USPTO.
  2. Oregon State University: Determining Inventorship for US Patent Applications.
  3. USPTO: Patent Claims Research Dataset.
  4. Harvard Business School Library: Patent search: A comparative table of databases.
  5. Maryland People's Law Library: Patents.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,792,278

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amicus Therap Us GALAFOLD migalastat hydrochloride CAPSULE;ORAL 208623-001 Aug 10, 2018 RX Yes Yes ⤷  Try for Free ⤷  Try for Free THE TREATMENT OF FABRY PATIENTS ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,792,278

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 111971 ⤷  Try for Free
Australia 2009214648 ⤷  Try for Free
Australia 2014221321 ⤷  Try for Free
Australia 2016206297 ⤷  Try for Free
Australia 2017268649 ⤷  Try for Free
Australia 2018220047 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.